Back
Sigma Lithium Vs. Akero Therapeutics Industry Stock Comparison
Sell
19
SGML
Sigma Lithium
Last Price:
$5.01
Seasonality Move:
24.23%
Buy
62
AKRO
Akero Therapeutics
Last Price:
$55.60
Seasonality Move:
13.24%
Sell
19
Sigma Lithium (SGML)
is a Sell
Is Sigma Lithium a Buy, Sell or Hold?
-
The current Sigma Lithium [SGML] share price is $5.13. The Score for SGML is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
SGML is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $53.56. The Score for AKRO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SGML Stock Price Chart
What is Sigma Lithium's stock price today?
-
The Sigma Lithium share price today is $5.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGML is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $53.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
SGML Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 37.1 | Sell |
Chaikin Money Flow: | -929294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.95 - 6.83) | Sell |
Bollinger Bands (100): | (6.73 - 11.51) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.15 | Buy |
Relative Strength Index (14 RSI): | 65.57 | Buy |
Chaikin Money Flow: | 717151 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.43 - 52.83) | Buy |
Bollinger Bands (100): | (36.98 - 51.74) | Buy |
SGML Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.27 | Sell |
20-day SMA: | 5.5 | Sell |
50-day SMA: | 6.94 | Sell |
200-day SMA: | 10.77 | Sell |
8-day EMA: | 5.32 | Sell |
20-day EMA: | 5.69 | Sell |
50-day EMA: | 6.99 | Sell |
200-day EMA: | 10.58 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.57 | Sell |
20-day SMA: | 48.83 | Buy |
50-day SMA: | 43.48 | Buy |
200-day SMA: | 36.65 | Buy |
8-day EMA: | 52.88 | Buy |
20-day EMA: | 49.78 | Buy |
50-day EMA: | 45.95 | Buy |
200-day EMA: | 38.39 | Buy |
Sigma Lithium Earnings Growth & SGML Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.18 per share, an increase this year of $0.26 per share, and an increase next year of $0.71 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Sigma Lithium Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |